We are live on ! Find out more
AIM

Aigen Investment Management Portfolio holdings

AUM $389M
1-Year Est. Return 16.77%
This Fund
S&P 500
This Quarter Est. Return
-3.1%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$55.2M
Cap. Flow
+$68.6M
Cap. Flow %
13.33%
Top 10 Hldgs %
9.21%
Holding
1,071
New
432
Increased
168
Reduced
133
Closed
338

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$5.06M
2
BMY icon
Bristol-Myers Squibb
BMY
+$4.91M
3
AZO icon
AutoZone
AZO
+$4.44M
4
PSX icon
Phillips 66
PSX
+$4.04M
5
RTX icon
RTX Corp
RTX
+$3.95M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.63M
2
AWK icon
American Water Works
AWK
+$4.76M
3
ROST icon
Ross Stores
ROST
+$4.03M
4
LIN icon
Linde
LIN
+$3.44M
5
AAPL icon
Apple
AAPL
+$3.19M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.15%
2 Technology 15.58%
3 Industrials 13.47%
4 Financials 11.94%
5 Healthcare 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADAM
951
Adamas Trust
ADAM
$883M
– –
-10,836
Closed -$78K
OKE icon
952
Oneok
OKE
$54.5B
– –
-5,171
Closed -$415K
OKTA icon
953
Okta
OKTA
$25.8B
– –
-2,447
Closed -$256K
ORA icon
954
Ormat Technologies
ORA
$6.65B
– –
-10,254
Closed -$679K
ORLY icon
955
O'Reilly Automotive
ORLY
$76.3B
– –
-5,370
Closed -$404K
OSCR icon
956
Oscar Health
OSCR
$8.61B
– –
-26,258
Closed -$390K
OTEX icon
957
Open Text
OTEX
$6.04B
– –
-11,115
Closed -$431K
OTIS icon
958
Otis Worldwide
OTIS
$28.2B
– –
-4,067
Closed -$404K
OZK icon
959
Bank OZK
OZK
$5.61B
– –
-4,600
Closed -$209K
PACB icon
960
Pacific Biosciences
PACB
$370M
– –
-28,098
Closed -$105K
PARR icon
961
Par Pacific Holdings
PARR
$3.32B
– –
-6,523
Closed -$242K
PARA
962
DELISTED
Paramount Global Class B
PARA
– –
-95,722
Closed -$1.13M
PBF icon
963
PBF Energy
PBF
$7.31B
– –
-4,038
Closed -$232K
PBR.A icon
964
Petrobras Class A
PBR.A
$103B
– –
-57,553
Closed -$858K
PFE icon
965
Pfizer
PFE
$153B
– –
-94,301
Closed -$2.62M
PFSI icon
966
PennyMac Financial
PFSI
$4.02B
– –
-3,661
Closed -$333K
PGRE
967
DELISTED
Paramount Group
PGRE
– –
-23,832
Closed -$112K
PHIN icon
968
Phinia Inc
PHIN
$2.74B
– –
-5,250
Closed -$202K
PLAY icon
969
Dave & Buster's
PLAY
$357M
– –
-7,886
Closed -$494K
PRCT icon
970
Procept Biorobotics
PRCT
$1.17B
– –
-5,727
Closed -$283K
PRTA icon
971
Prothena Corp
PRTA
$450M
– –
-9,901
Closed -$245K
PVH icon
972
PVH
PVH
$4.04B
– –
-9,649
Closed -$1.36M
PZZA icon
973
Papa John's
PZZA
$806M
– –
-7,864
Closed -$524K
QCOM icon
974
Qualcomm
QCOM
$176B
– –
-1,566
Closed -$265K
RAPT
975
DELISTED
RAPT Therapeutics
RAPT
– –
-1,868
Closed -$134K
37 38
39
40 41

Similar funds

SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
SI
Schusterman Interests Tulsa, Oklahoma $391M AUM 33.81% 1-Year Est. Return
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Aigen Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Aigen Investment Management held 1,071 positions worth $514M, up 12% from $459M the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Aigen Investment Management deployed $68.6M of net new capital in Q2 2024, opening 432 new positions and adding to 168 existing holdings. Its largest new stake was Visa: 18,454 shares worth $4.84M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Hess, an estimated $2.91M trimmed.

  • Aigen Investment Management's largest Q2 2024 buy was Visa: 18,454 shares worth $4.84M.
  • Aigen Investment Management added most to Bristol-Myers Squibb in Q2 2024, an estimated $4.91M increase.
  • Aigen Investment Management's biggest Q2 2024 reduction was Hess, cutting an estimated $2.91M.
  • Aigen Investment Management fully exited Eli Lilly in Q2 2024, selling an estimated $6.63M.
  • Aigen Investment Management's ten largest holdings make up 9.2% of its $514M portfolio in Q2 2024.
  • Aigen Investment Management opened 432 new positions and closed 338 in Q2 2024.
  • Aigen Investment Management's portfolio value rose 12% quarter-over-quarter to $514M.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.